39. Vita Pharmaceutical Co. is considering four proposals for the expansion of its dietary supplements production facility. The investment requirements and the cash flows for an 8-year period are presented below.
P1
P2
P3
P4
Initial Investment
P13M
P14.5M
P15M
15.8M
Annual Receipts
1.5M
1.6M
1.7M
2.2M
Annual Disbursements
0.7M
0.5M
0.65M
Salvage Value
1.3M
2M
2.5M
Determine the best alternative if the company applies a 14% MARR of its investments.
(Ans. Consider P4; i2-1=13.27% ; i3-1=5.91% ; i4-1=21.76%)
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here